Research
Print page Print page
Switch language
The Capital Region of Denmark - a part of Copenhagen University Hospital
Published

Partial Oral versus Intravenous Antibiotic Treatment of Endocarditis

Research output: Contribution to journalJournal articleResearchpeer-review

DOI

  1. Partial Oral Therapy for Osteomyelitis and Endocarditis. Reply

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Oral Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Application of High-Sensitivity Troponin in Suspected Myocardial Infarction

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Venetoclax and Obinutuzumab in Patients with CLL and Coexisting Conditions

    Research output: Contribution to journalJournal articleResearchpeer-review

  5. Long-Term Outcomes of Partial Oral Treatment of Endocarditis

    Research output: Contribution to journalLetterResearch

  1. Partial Oral Therapy for Osteomyelitis and Endocarditis. Reply

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Polygenic predisposition to breast cancer and the risk of coronary artery disease

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Cardiovascular Manifestations of Systemic Sclerosis: A Danish Nationwide Cohort Study

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Duration of Heart Failure and Effect of Defibrillator Implantation in Patients With Nonischemic Systolic Heart Failure

    Research output: Contribution to journalJournal articleResearchpeer-review

View graph of relations

BACKGROUND Patients with infective endocarditis on the left side of the heart are typically treated with intravenous antibiotic agents for up to 6 weeks. Whether a shift from intravenous to oral antibiotics once the patient is in stable condition would result in efficacy and safety similar to those with continued intravenous treatment is unknown. METHODS In a randomized, noninferiority, multicenter trial, we assigned 400 adults in stable condition who had endocarditis on the left side of the heart caused by streptococcus, Enterococcus faecalis, Staphylococcus aureus, or coagulase-negative staphylococci and who were being treated with intravenous antibiotics to continue intravenous treatment (199 patients) or to switch to oral antibiotic treatment (201 patients). In all patients, antibiotic treatment was administered intravenously for at least 10 days. If feasible, patients in the orally treated group were discharged to outpatient treatment. The primary outcome was a composite of all-cause mortality, unplanned cardiac surgery, embolic events, or relapse of bacteremia with the primary pathogen, from the time of randomization until 6 months after antibiotic treatment was completed. RESULTS After randomization, antibiotic treatment was completed after a median of 19 days (interquartile range, 14 to 25) in the intravenously treated group and 17 days (interquartile range, 14 to 25) in the orally treated group (P=0.48). The primary composite outcome occurred in 24 patients (12.1%) in the intravenously treated group and in 18 (9.0%) in the orally treated group (between-group difference, 3.1 percentage points; 95% confidence interval, −3.4 to 9.6; P=0.40), which met noninferiority criteria. CONCLUSIONS In patients with endocarditis on the left side of the heart who were in stable condition, changing to oral antibiotic treatment was noninferior to continued intravenous antibiotic treatment.

Original languageEnglish
JournalThe New England journal of medicine
Volume380
Issue number5
Pages (from-to)415-424
Number of pages10
ISSN0028-4793
DOIs
Publication statusPublished - 31 Jan 2019

    Research areas

  • Administration, Intravenous, Administration, Oral, Aged, Anti-Bacterial Agents/administration & dosage, Bacteremia/drug therapy, Endocarditis, Bacterial/drug therapy, Female, Heart Valve Prosthesis/microbiology, Humans, Intention to Treat Analysis, Kaplan-Meier Estimate, Length of Stay, Male, Middle Aged, Recurrence

ID: 55417028